While women with breast cancer who have used hormone-replacement therapy are known to have better survival odds than those who've never taken hormones, the advantage is due, most likely, to more-frequent mammography screening rather than the effect of the hormones on tumor biology, according to new findings by researchers at Fred Hutchinson Cancer Research Center.
"Most of the good prognostic factors that have been ascribed to HRT - such as smaller tumor size and earlier cancer stage at diagnosis - may simply be an artifact of screening," said Janet Daling, Ph.D., lead author of the paper, which appears in the current (November) issue of Cancer Epidemiology, Biomarkers and Prevention.
"In many cases probably the HRT itself is doing nothing, other than getting women to the doctor once a year for a prescription renewal - and a mammogram," said Daling, a member of Fred Hutchinson's Public Health Sciences Division.
Daling and co-authors from five study sites nationwide reported that 90 percent of women who used combination estrogen/progestin HRT had undergone a screening mammogram within two years of breast-cancer diagnosis. In contrast, only 65 percent of women with breast cancer who'd never used HRT had undergone a mammogram during that time period.
The difference in tumor size between the two groups was significant. Among women who'd been screened within two years of diagnosis, 67 percent had tumors smaller than 2 centimeters (about the size of a pea), whereas only about 34 percent of women who hadn't been screened had tumors that small.
"I was floored when I saw this data," Daling said, "because tumor size is one of the most important prognostic factors in breast cancer. The difference in the size of the tumors between the two groups was staggering. If that isn't a good advertisement for mammography screening, then I don't know what is."
The findings were based on data from the Women's CARE (Contraceptive and Reproductive EPage: 1 2 3 4 Related medicine news :1
Contact: Kristen Woodward
Fred Hutchinson Cancer Research Center
. International breast cancer prevention study launches in the United States and Canada2
. Unexpected benefit seen in treating HER-2 breast cancer with new preoperative drug combo3
. Risk of cardiac death after radiotherapy for breast cancer has declined, study finds4
. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased5
. Study shows acrylamide in baked and fried food does not increase risk of breast cancer in women6
. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans7
. Postmenopausal breast cancer survivors at increased risk for bone fractures8
. Nursing mothers having surgery -- How long a wait to breastfeed safely?9
. Researchers close in on breast cancer vaccine10
. Simple question from your doctor can help identify your risk for breast cancer11
. Non-invasive and invasive breast cancers share the same genetic mutations